4.3 Article

Hermansky-Pudlak Syndrome

Journal

CLINICS IN CHEST MEDICINE
Volume 37, Issue 3, Pages 505-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccm.2016.04.012

Keywords

Pulmonary fibrosis; Interstitial lung disease; Albinism; Biogenesis of lysosome-related organelle complex; Adaptor protein 3; Hermansky-Pudlak syndrome

Funding

  1. NIH/NHLBI [R01 HL119503]
  2. NIH/NCATS/NHLBI [U54 HL127672]
  3. ATS Foundation/American Lung Association
  4. NCATS
  5. National Heart, Lung, and Blood Institute
  6. Rare Lung Diseases Consortium is part of the Rare Diseases Clinical Research Network
  7. Office of Rare Diseases Research (ORDR)
  8. National Center for Advancing Translational Sciences (NCATS)

Ask authors/readers for more resources

Hermansky-Pudlak syndrome (HPS) is an autosomal recessive disorder that is associated with oculocutaneous albinism, bleeding diatheses, granulomatous colitis, and highly penetrant pulmonary fibrosis in some subtypes, including HPS-1, HPS-2, and HPS-4. HPS pulmonary fibrosis shows many of the clinical, radiologic, and histologic features found in idiopathic pulmonary fibrosis, but occurs at a younger age. Despite knowledge of the underlying genetic defects, there are currently no definitive therapeutic or preventive approaches for HPS pulmonary fibrosis other than lung transplant.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available